NO1999007I1 - Lacidipin - Google Patents

Lacidipin

Info

Publication number
NO1999007I1
NO1999007I1 NO1999007C NO1999007C NO1999007I1 NO 1999007 I1 NO1999007 I1 NO 1999007I1 NO 1999007 C NO1999007 C NO 1999007C NO 1999007 C NO1999007 C NO 1999007C NO 1999007 I1 NO1999007 I1 NO 1999007I1
Authority
NO
Norway
Prior art keywords
lacidipine
Prior art date
Application number
NO1999007C
Other languages
English (en)
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT22383/84A external-priority patent/IT1175620B/it
Priority claimed from IT21460/85A external-priority patent/IT1187678B/it
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of NO1999007I1 publication Critical patent/NO1999007I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2205/00—Fibre drawing or extruding details
    • C03B2205/44—Monotoring or regulating the preform feed rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO1999007C 1984-08-22 1999-04-23 Lacidipin NO1999007I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22383/84A IT1175620B (it) 1984-08-22 1984-08-22 Derivati piridinici
IT21460/85A IT1187678B (it) 1985-07-05 1985-07-05 Procedimento di preparazione di derivati eterociclici

Publications (1)

Publication Number Publication Date
NO1999007I1 true NO1999007I1 (no) 1999-04-23

Family

ID=26327905

Family Applications (2)

Application Number Title Priority Date Filing Date
NO853293A NO167142C (no) 1984-08-22 1985-08-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO1999007C NO1999007I1 (no) 1984-08-22 1999-04-23 Lacidipin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO853293A NO167142C (no) 1984-08-22 1985-08-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.

Country Status (33)

Country Link
US (2) US4801599A (no)
JP (2) JPS6193162A (no)
KR (1) KR920004482B1 (no)
AT (1) AT394042B (no)
AU (1) AU578724B2 (no)
BE (1) BE903103A (no)
BG (1) BG60409B2 (no)
CA (1) CA1268180A (no)
CH (1) CH666684A5 (no)
CS (1) CS403091A3 (no)
CY (1) CY1494A (no)
DE (1) DE3529997C2 (no)
DK (1) DK165949C (no)
ES (5) ES8703839A1 (no)
FI (1) FI81568C (no)
FR (1) FR2569402B1 (no)
GB (1) GB2164336B (no)
GR (1) GR852016B (no)
HK (1) HK52990A (no)
HU (1) HU196754B (no)
IE (1) IE58486B1 (no)
LU (2) LU88267I2 (no)
MX (1) MX159974A (no)
NL (2) NL193065C (no)
NO (2) NO167142C (no)
NZ (1) NZ212895A (no)
PH (1) PH22014A (no)
PT (1) PT81000B (no)
SA (1) SA91120277B1 (no)
SE (1) SE459920B (no)
SG (1) SG40889G (no)
SK (1) SK278327B6 (no)
ZW (1) ZW13185A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
CA1337295C (en) * 1985-08-21 1995-10-10 Claudio Semeraro Dihydropyridine derivatives and their preparation and pharmaceutical formulation
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204461B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1233370B (it) * 1988-11-21 1992-03-27 Glaxo Spa Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari
DE69030982T2 (de) 1989-04-27 1997-11-13 Canon Kk Optisches Aufzeichnungsmedium und Verfahren zu seiner Herstellung
US5177202A (en) * 1990-10-09 1993-01-05 Merck & Co., Inc. 2-phenanthrenyl-carbapenems
US5196529A (en) * 1990-10-09 1993-03-23 Merck & Co., Inc. 2-phenanthrenyl carbapenem intermediates
US5132421A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5132422A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5144028A (en) * 1990-10-09 1992-09-01 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5356889A (en) * 1990-08-01 1994-10-18 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5208329A (en) * 1990-10-09 1993-05-04 Merck & Co., Inc. 2-biphenyl carbapenem intermediates
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
AU1042199A (en) * 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Antihypertensive medicaments containing lacidipine and telmisartan
RS20050106A (en) 2002-08-19 2007-11-15 Pfizer Products Inc., Combination therapy for hyperproliferative diseases
SG141430A1 (en) * 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060147520A1 (en) * 2004-07-26 2006-07-06 Curtis Ruegg Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
WO2006113309A1 (en) 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
US20070043088A1 (en) * 2005-08-16 2007-02-22 Eswaraiah Sajja Process for preparing lacidipine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP1951253A2 (en) * 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
US20080153896A1 (en) * 2006-07-14 2008-06-26 Gyan Chand Yadav Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
LT2705839T (lt) 2012-09-10 2018-06-11 Rivopharm Sa Farmacinė kompozicija, apimanti lacidipiną ir jos gavimo būdas
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
IE852054L (en) 1986-02-22
NO853293L (no) 1986-02-24
ES8802497A1 (es) 1988-07-01
MX159974A (es) 1989-10-17
ES8707930A1 (es) 1987-09-01
NO167142C (no) 1991-10-09
JPS6193162A (ja) 1986-05-12
FI853206L (fi) 1986-02-23
JPH0686430B2 (ja) 1994-11-02
ATA245485A (de) 1991-07-15
AU578724B2 (en) 1988-11-03
HUT40625A (en) 1987-01-28
SE8503888L (sv) 1986-02-23
LU86047A1 (fr) 1986-02-28
ES552048A0 (es) 1987-09-01
SG40889G (en) 1989-12-22
DK165949B (da) 1993-02-15
GB2164336B (en) 1988-06-08
NL980037I1 (nl) 1999-02-01
AU4657685A (en) 1986-02-27
PH22014A (en) 1988-05-02
ES552050A0 (es) 1987-09-01
SA91120277B1 (ar) 2006-05-15
JPS6479152A (en) 1989-03-24
FI81568B (fi) 1990-07-31
GB2164336A (en) 1986-03-19
ES8703839A1 (es) 1987-03-01
SE8503888D0 (sv) 1985-08-20
NL8502296A (nl) 1986-03-17
PT81000B (pt) 1988-03-03
CY1494A (en) 1990-02-16
AT394042B (de) 1992-01-27
FI853206A0 (fi) 1985-08-21
CA1268180A (en) 1990-04-24
US5011848A (en) 1991-04-30
FR2569402A1 (fr) 1986-02-28
NL193065C (nl) 1998-09-08
KR870002073A (ko) 1987-03-28
HU196754B (en) 1989-01-30
DK378085A (da) 1986-02-23
ES552051A0 (es) 1987-09-01
NO167142B (no) 1991-07-01
CS403091A3 (en) 1992-06-17
SE459920B (sv) 1989-08-21
SK278327B6 (en) 1996-11-06
HK52990A (en) 1990-07-20
FR2569402B1 (fr) 1989-09-22
GR852016B (no) 1985-12-19
GB8520924D0 (en) 1985-09-25
NL193065B (nl) 1998-05-06
LU88267I2 (no) 1994-02-03
BG60409B2 (bg) 1995-02-28
US4801599A (en) 1989-01-31
PT81000A (en) 1985-09-01
ES546324A0 (es) 1987-03-01
ES8707931A1 (es) 1987-09-01
DE3529997C2 (de) 1996-01-18
ES552049A0 (es) 1988-07-01
NL980037I2 (nl) 1999-03-01
KR920004482B1 (ko) 1992-06-05
BE903103A (fr) 1986-02-24
DE3529997A1 (de) 1986-03-06
DK165949C (da) 1993-07-05
IE58486B1 (en) 1993-09-22
FI81568C (fi) 1990-11-12
JPH0550506B2 (no) 1993-07-29
ES8707932A1 (es) 1987-09-01
DK378085D0 (da) 1985-08-20
ZW13185A1 (en) 1986-03-19
CH666684A5 (de) 1988-08-15
NZ212895A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
NO1999007I1 (no) Lacidipin
AT380762B (de) Hoergeraet
SE8501133L (sv) Brenslesystem
AT379929B (de) Hoergeraet
ES296301Y (es) Mandril-portabrocas
FI840024A0 (fi) Instaellbart saengbotten
DK155985D0 (da) Cephem-derivater
ATA98284A (de) Schalplatte
ATA135485A (de) Maishaecksler
SE8500029L (sv) Golvbeleggningsmaterial
AT386724B (de) Haecksler
IT1201984B (it) Draga
ATA237384A (de) Maehwerk
DK415985A (da) Etherherbicider
DK332485A (da) Venestripper
DK582985A (da) Gasturbulator
FI840075A0 (fi) Saerskilt foer lek- eller konditionsredskap avsedd fjaederkonstruktion
FI840940A0 (fi) Vattenbehandling foer barkerier
ATA187784A (de) Vulkanisierform
ATA45484A (de) Kimme
AT389296B (de) Elektrokoagulator
AR231237A1 (es) Calzado-patin
SE8402087D0 (sv) Rokgasreningsutrustning
DK448484D0 (da) Stigeklo
FI840773A0 (fi) Lyftanordning foer vaetskor